Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma
Clinical trial NCT00768144 · COMPLETED
Trial details
- NCT number
- NCT00768144
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2012-05-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.